Canadian exports of cannabis oil merchandise and dried marijuana for medical and scientific use have soared. (See chart under.)
In 2019, greater than 5,000 liters (1,321 gallons) of cannabis oil merchandise had been exported for medical (industrial) and scientific use to 17 nations. Most of that went to Australia.
Roughly 3,740 kilograms (8,245 kilos) of dried cannabis for medical and scientific use was shipped abroad in 2019. Somewhat greater than 94% of that went to Germany.
One of the most important points going through medical cannabis exporters, together with these from Canada, is a restricted quantity of abroad markets.
The checklist of nations eager to export industrial medical cannabis is rising by the month, however the quantity of nations importing significant portions is proscribed to a handful that features Australia, Brazil, Germany and, solely lately, Israel.
That makes the Canadian market all of the extra interesting to regulated cannabis producers who’ve their sights set abroad.
But Canada imported nearly no cannabis for medical or scientific use between October 2018 and March 2019 – the newest interval for which knowledge is out there.
Industry sources say it’s unlikely any industrial imports have occurred since then.
Jamaica to enchantment
Jamaica is one of the nations hoping to capitalize on exports of medical marijuana.
But business and authorities sources there say the Canadian authorities is standing in the way in which.
“It appears manifestly clear that the refusal of the Canadian government to allow the importation of commercial quantities of marijuana from Jamaica is putting the investment of several Canadian investors in Jamaica at risk,” Audley Shaw, Jamaica’s minister of Industry, Commerce, Agriculture and Fisheries, mentioned in an announcement to MJBizDaily.
“In fact, several Canadian investors have already closed down their operations in Jamaica because of this.”
Shaw mentioned Jamaica will make a proper enchantment to the Canadian authorities “for this unfortunate position to be reviewed.”
Jacana, a number one firm within the Caribbean medical cannabis business, has tried however didn’t ship its merchandise to a Canadian licensed producer on the market to sufferers.
“We have worked with several Canadian LPs who have attempted to get an import permit from Health Canada, and in each instance, there has been no clear guidance as to why it is not possible,” Jacana CEO Alexandra Chong informed Marijuana Business Daily.
Chong couldn’t establish the businesses as a result of of nondisclosure agreements.
“In the continued absence of guidance from Health Canada,” she mentioned, “one can only assume that there is an element of protectionism at play regarding medical cannabis importation.”
Chong mentioned the import scenario in Canada “will no doubt soon be challenged by other countries as the industry matures.”
Jacana endured a 13-month course of that began in January 2019 and led to February 2020.
When an import allow was finally accepted by Health Canada, the situations for importing 10 kilograms of dried cannabis said:
- It “cannot be sold to provinces, territories or to medical clients.”
- It “cannot be exported out of Canada.”
Colombia, Australia considerations
As Colombia and Australia grow to be goal markets for Canadian producers, licensed corporations there have famous their incapacity to entry the Canadian market.
Some executives requested anonymity to keep away from jeopardizing ongoing talks with the Canadian regulator.
A multinational firm with manufacturing belongings in Colombia mentioned Canada’s evident determination to dam imports impacts sufferers essentially the most, “and it is Health Canada’s role to care about these patients.”
“They’re not respecting international trade obligations. You can’t allow exports but not imports,” the business supply mentioned.
“This is something that’s very specific and targeted to the needs of Canadian patients in Canada. This is not a floodgates issue. This is about products that our partners are telling us patients need, and they’re not here.
“They’re pharma-grade and more affordable than what is available currently in Canada, and there’s no reason they cannot be let in.”
Fleta Solomon, CEO of Little Green Pharma, mentioned the Australian producer has been ready about two years for an import allow to do enterprise with a Canadian firm.
“A number of months ago after hearing nothing, our Canadian partner agreed that it was likely Health Canada has decided not to allow import for commercial use as there is too much product in the country,” she informed Marijuana Business Daily. “We’ve stopped following up and have moved on to other jurisdictions.”
“Patients deserve the right to access quality pharmaceutical-grade medicines that have undergone rigorous testing just like all other prescribed medicines.”